112 related articles for article (PubMed ID: 17161515)
1. Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.
Park HR; Ryoo IJ; Choo SJ; Hwang JH; Kim JY; Cha MR; Shin-Ya K; Yoo ID
Toxicology; 2007 Jan; 229(3):253-61. PubMed ID: 17161515
[TBL] [Abstract][Full Text] [Related]
2. Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator.
Hwang JH; Kim JY; Cha MR; Ryoo IJ; Choo SJ; Cho SM; Tsukumo Y; Tomida A; Shin-Ya K; Hwang YI; Yoo ID; Park HR
J Cell Physiol; 2008 Apr; 215(1):243-50. PubMed ID: 17941090
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity of Ponciri Fructus against glucose-deprived PANC-1 human pancreatic cancer cells via blocking activation of GRP78.
Cha MR; Yoon MY; Son ES; Park HR
Biosci Biotechnol Biochem; 2009 Oct; 73(10):2167-71. PubMed ID: 19809193
[TBL] [Abstract][Full Text] [Related]
4. Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.
Kim JY; Hwang JH; Cha MR; Yoon MY; Son ES; Tomida A; Ko B; Song SW; Shin-ya K; Hwang YI; Park HR
J Cell Physiol; 2010 Jul; 224(1):33-40. PubMed ID: 20232300
[TBL] [Abstract][Full Text] [Related]
5. Deoxyverrucosidin, a novel GRP78/BiP down-regulator, produced by Penicillium sp.
Choo SJ; Park HR; Ryoo IJ; Kim JP; Yun BS; Kim CJ; Shin-ya K; Yoo ID
J Antibiot (Tokyo); 2005 Mar; 58(3):210-3. PubMed ID: 15895531
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of epidermal growth factor receptor-signaling pathway by binding of GRP78/BiP to the receptor under glucose-starved stress conditions.
Cai B; Tomida A; Mikami K; Nagata K; Tsuruo T
J Cell Physiol; 1998 Nov; 177(2):282-8. PubMed ID: 9766525
[TBL] [Abstract][Full Text] [Related]
7. Mithramycin inhibits etoposide resistance in glucose-deprived HT-29 human colon carcinoma cells.
Lee EM; Park HR; Hwang JH; Park DJ; Chang KS; Kim CJ
J Microbiol Biotechnol; 2007 Nov; 17(11):1856-61. PubMed ID: 18092471
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
[TBL] [Abstract][Full Text] [Related]
9. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
Ramsay RG; Ciznadija D; Mantamadiotis T; Anderson R; Pearson R
Int J Biochem Cell Biol; 2005 Jun; 37(6):1254-68. PubMed ID: 15778089
[TBL] [Abstract][Full Text] [Related]
10. Selective cytotoxic activity of valinomycin against HT-29 Human colon carcinoma cells via down-regulation of GRP78.
Ryoo IJ; Park HR; Choo SJ; Hwang JH; Park YM; Bae KH; Shin-Ya K; Yoo ID
Biol Pharm Bull; 2006 Apr; 29(4):817-20. PubMed ID: 16595926
[TBL] [Abstract][Full Text] [Related]
11. Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells.
Suzuki T; Lu J; Zahed M; Kita K; Suzuki N
Arch Biochem Biophys; 2007 Dec; 468(1):1-14. PubMed ID: 17936241
[TBL] [Abstract][Full Text] [Related]
12. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
13. HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.
Xiao X; Li S; Zhang X; Lu J; Wang W; Zhou S; Zhang J; Wang R; Li A
Toxicol Appl Pharmacol; 2019 Jun; 373():10-25. PubMed ID: 31022492
[TBL] [Abstract][Full Text] [Related]
14. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
Pootrakul L; Datar RH; Shi SR; Cai J; Hawes D; Groshen SG; Lee AS; Cote RJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5987-93. PubMed ID: 17062670
[TBL] [Abstract][Full Text] [Related]
15. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.
Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R
Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518
[TBL] [Abstract][Full Text] [Related]
16. Decreased cell survival and DNA repair capacity after UVC irradiation in association with down-regulation of GRP78/BiP in human RSa cells.
Zhai L; Kita K; Wano C; Wu Y; Sugaya S; Suzuki N
Exp Cell Res; 2005 May; 305(2):244-52. PubMed ID: 15817150
[TBL] [Abstract][Full Text] [Related]
17. Efrapeptin J, a new down-regulator of the molecular chaperone GRP78 from a marine Tolypocladium sp.
Hayakawa Y; Hattori Y; Kawasaki T; Kanoh K; Adachi K; Shizuri Y; Shin-ya K
J Antibiot (Tokyo); 2008 Jun; 61(6):365-71. PubMed ID: 18667784
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of molecular chaperone 78-kd glucose-regulated protein/immunoglobulin-binding protein expression involved in enhancement of human RS cell mutability.
Hirano J; Kita K; Sugaya S; Ichimura Y; Yamamori H; Nakajima N; Suzuki N
Pancreas; 2008 Jan; 36(1):e7-14. PubMed ID: 18192872
[TBL] [Abstract][Full Text] [Related]
19. Absolute structure of prunustatin A, a novel GRP78 molecular chaperone down-regulator.
Umeda Y; Furihata K; Sakuda S; Nagasawa H; Ishigami K; Watanabe H; Izumikawa M; Takagi M; Doi T; Nakao Y; Shin-ya K
Org Lett; 2007 Oct; 9(21):4239-42. PubMed ID: 17887691
[TBL] [Abstract][Full Text] [Related]
20. Effect on tumor cells of blocking survival response to glucose deprivation.
Park HR; Tomida A; Sato S; Tsukumo Y; Yun J; Yamori T; Hayakawa Y; Tsuruo T; Shin-ya K
J Natl Cancer Inst; 2004 Sep; 96(17):1300-10. PubMed ID: 15339968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
